AR089631A1 - FORMA CRISTALINA d DE LA SAL DE ARGININA DE PERINDOPRILO, SU PROCEDIMIENTO DE PREPARACION, Y LAS COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN - Google Patents
FORMA CRISTALINA d DE LA SAL DE ARGININA DE PERINDOPRILO, SU PROCEDIMIENTO DE PREPARACION, Y LAS COMPOSICIONES FARMACEUTICAS QUE LA CONTIENENInfo
- Publication number
- AR089631A1 AR089631A1 ARP130100015A ARP130100015A AR089631A1 AR 089631 A1 AR089631 A1 AR 089631A1 AR P130100015 A ARP130100015 A AR P130100015A AR P130100015 A ARP130100015 A AR P130100015A AR 089631 A1 AR089631 A1 AR 089631A1
- Authority
- AR
- Argentina
- Prior art keywords
- arginine salt
- perindoprile
- pharmaceutical compositions
- compositions containing
- crystal form
- Prior art date
Links
- 150000001483 arginine derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052802 copper Inorganic materials 0.000 abstract 2
- 239000010949 copper Substances 0.000 abstract 2
- 238000010586 diagram Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- RYCSJJXKEWBUTI-YDYAIEMNSA-N perindopril arginine Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 RYCSJJXKEWBUTI-YDYAIEMNSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B43/00—Forming, feeding, opening or setting-up containers or receptacles in association with packaging
- B65B43/42—Feeding or positioning bags, boxes, or cartons in the distended, opened, or set-up state; Feeding preformed rigid containers, e.g. tins, capsules, glass tubes, glasses, to the packaging position; Locating containers or receptacles at the filling position; Supporting containers or receptacles during the filling operation
- B65B43/46—Feeding or positioning bags, boxes, or cartons in the distended, opened, or set-up state; Feeding preformed rigid containers, e.g. tins, capsules, glass tubes, glasses, to the packaging position; Locating containers or receptacles at the filling position; Supporting containers or receptacles during the filling operation using grippers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
- B65G47/00—Article or material-handling devices associated with conveyors; Methods employing such devices
- B65G47/74—Feeding, transfer, or discharging devices of particular kinds or types
- B65G47/90—Devices for picking-up and depositing articles or materials
- B65G47/91—Devices for picking-up and depositing articles or materials incorporating pneumatic, e.g. suction, grippers
- B65G47/912—Devices for picking-up and depositing articles or materials incorporating pneumatic, e.g. suction, grippers provided with drive systems with rectilinear movements only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
- B65G2201/00—Indexing codes relating to handling devices, e.g. conveyors, characterised by the type of product or load being conveyed or handled
- B65G2201/02—Articles
- B65G2201/0235—Containers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Forma cristalina d del compuesto de fórmula (1) caracterizada por su diagrama de difracción X sobre polvo. Medicamentos. Reivindicación 1: Forma cristalina d de la sal de L-arginina de perindoprilo, de fórmula (1) caracterizada por los picos de difracción RX sobre polvo siguientes, medidos en un difractómetro con anticátodo de cobre y expresados en términos de ángulo de Bragg 2q (º): 4,3, 11,0, 11,1, 13,2, 14,6, 16,0 y 21,9. Reivindicación 3: Forma cristalina d del compuesto de fórmula (1) según la reivindicación 1, caracterizada por el diagrama de difracción X sobre polvo siguiente, medido en un difractómetro con anticátodo de cobre y expresado en términos de distancia inter-reticular d, de ángulo de Bragg 2q y de intensidad relativa, expresada en porcentaje respecto a la línea más intensa: @@@@@@@@@
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1200033A FR2985511B1 (fr) | 2012-01-05 | 2012-01-05 | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR089631A1 true AR089631A1 (es) | 2014-09-03 |
Family
ID=47427277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100015A AR089631A1 (es) | 2012-01-05 | 2013-01-03 | FORMA CRISTALINA d DE LA SAL DE ARGININA DE PERINDOPRILO, SU PROCEDIMIENTO DE PREPARACION, Y LAS COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN |
Country Status (44)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
| CN110283104B (zh) * | 2018-08-22 | 2022-06-14 | 南京济群医药科技股份有限公司 | 一种精氨酸培哚普利的制备方法 |
| EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
| SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
| CN114149357B (zh) * | 2021-12-29 | 2024-06-25 | 江苏嘉逸医药有限公司 | 一种γ晶型培哚普利精氨酸盐的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| FR2620703B1 (fr) * | 1987-09-17 | 1991-10-04 | Adir | Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides |
| JPH04352788A (ja) * | 1990-08-30 | 1992-12-07 | Kanebo Ltd | 新規キノリンカルボン酸誘導体、該化合物を有効成分とする抗菌剤および該化合物の製造方法 |
| JP4028894B2 (ja) * | 1996-08-09 | 2007-12-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ベンゾピペリジン誘導体 |
| FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
| JP4402361B2 (ja) * | 2003-03-31 | 2010-01-20 | 大日本印刷株式会社 | 塩酸エピナスチンの結晶多形 |
| AU2006281681A1 (en) * | 2005-08-12 | 2007-02-22 | Sandoz Ag | New crystalline form of perindopril erbumine |
| FR2897865B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| FR2897866B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| EP1864973A1 (en) * | 2006-06-09 | 2007-12-12 | Sochinaz SA | Process for the preparation of perindopril and salts thereof |
| NZ588145A (en) * | 2008-04-01 | 2013-05-31 | Lumavita Ag | Highly pure pentamycin |
| CA2729604C (en) * | 2008-06-24 | 2017-12-05 | Matrix Laboratories Ltd. | Polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
| AU2009212902A1 (en) * | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
| SI23001A (sl) * | 2009-03-20 | 2010-09-30 | Diagen@d@o@o | Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
| CN102114017A (zh) * | 2011-01-05 | 2011-07-06 | 王定豪 | 包含氨氯地平和培哚普利的药物组合物及其应用 |
-
2012
- 2012-01-05 FR FR1200033A patent/FR2985511B1/fr not_active Expired - Fee Related
- 2012-12-18 PH PH12012000393A patent/PH12012000393A1/en unknown
- 2012-12-19 CR CR20120655A patent/CR20120655A/es unknown
- 2012-12-19 SG SG2012093571A patent/SG192336A1/en unknown
- 2012-12-19 JO JOP/2012/0385A patent/JO3084B1/ar active
- 2012-12-20 AU AU2012268815A patent/AU2012268815B2/en active Active
- 2012-12-20 PE PE2012002462A patent/PE20131327A1/es not_active Application Discontinuation
- 2012-12-20 IL IL223752A patent/IL223752A/en active IP Right Grant
- 2012-12-25 TN TNP2012000619A patent/TN2012000619A1/fr unknown
- 2012-12-26 CO CO12232915A patent/CO6700139A1/es unknown
- 2012-12-27 UY UY0001034552A patent/UY34552A/es not_active Application Discontinuation
- 2012-12-27 NI NI201200194A patent/NI201200194A/es unknown
- 2012-12-27 MY MYPI2012701294A patent/MY176877A/en unknown
- 2012-12-27 TW TW101150658A patent/TWI471307B/zh active
- 2012-12-28 EA EA201201668A patent/EA022574B1/ru unknown
- 2012-12-28 MD MDA20120130A patent/MD4350C1/ro active IP Right Grant
-
2013
- 2013-01-02 MA MA35526A patent/MA35002B1/fr unknown
- 2013-01-02 SA SA113340173A patent/SA113340173B1/ar unknown
- 2013-01-02 AP AP2013006657A patent/AP2013006657A0/xx unknown
- 2013-01-03 BR BR102013000161-9A patent/BR102013000161B1/pt active IP Right Grant
- 2013-01-03 US US13/733,339 patent/US8835652B2/en active Active
- 2013-01-03 AR ARP130100015A patent/AR089631A1/es not_active Application Discontinuation
- 2013-01-03 CL CL2013000021A patent/CL2013000021A1/es unknown
- 2013-01-03 CA CA2800946A patent/CA2800946C/fr not_active Expired - Fee Related
- 2013-01-03 UA UAA201300119A patent/UA111334C2/uk unknown
- 2013-01-04 DK DK13150296.5T patent/DK2612850T3/da active
- 2013-01-04 GE GEAP201312950A patent/GEP20146182B/en unknown
- 2013-01-04 CU CU2013000001A patent/CU20130001A7/es unknown
- 2013-01-04 WO PCT/FR2013/050018 patent/WO2013102741A1/fr active Application Filing
- 2013-01-04 PT PT131502965T patent/PT2612850E/pt unknown
- 2013-01-04 CN CN201310001506.XA patent/CN103193864B/zh active Active
- 2013-01-04 KR KR1020130001017A patent/KR101502945B1/ko active IP Right Grant
- 2013-01-04 PL PL13150296T patent/PL2612850T3/pl unknown
- 2013-01-04 SI SI201330001T patent/SI2612850T1/sl unknown
- 2013-01-04 JP JP2013000107A patent/JP5722923B2/ja active Active
- 2013-01-04 EP EP13150296.5A patent/EP2612850B1/fr active Active
- 2013-01-04 ES ES13150296.5T patent/ES2439871T3/es active Active
- 2013-01-04 EC ECSP13012365 patent/ECSP13012365A/es unknown
- 2013-01-04 GT GT201300003A patent/GT201300003A/es unknown
- 2013-01-04 RS RS20130450A patent/RS53001B/en unknown
- 2013-01-07 MX MX2013000013A patent/MX2013000013A/es active IP Right Grant
- 2013-12-04 CY CY20131101094T patent/CY1114704T1/el unknown
- 2013-12-05 HR HRP20131164AT patent/HRP20131164T1/hr unknown
-
2014
- 2014-01-06 HK HK14100092.1A patent/HK1187061A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122222T1 (el) | Συνθεση βορονικων αλατων και χρησεις αυτων | |
| BR112015021983A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| UY35590A (es) | Nuevos compuestos para el tratamiento del cáncer | |
| CR20200276A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059) | |
| ECSP13012426A (es) | Promotores de apoptosis de n-acilsulfonamidas | |
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| IN2014CN04530A (es) | ||
| ECSP14026138A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
| EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
| CR20150456A (es) | Sal abexinostate novedosos asociados en forma cristalina, procedimiento de preparación y composiciones farmacéuticas que los contienen | |
| MD20160053A2 (ro) | Derivaţi ai purinei 2,6-substituite şi utilizarea acestora în tratamentul tulburărilor proliferative | |
| CO6821935A2 (es) | Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos | |
| AR089631A1 (es) | FORMA CRISTALINA d DE LA SAL DE ARGININA DE PERINDOPRILO, SU PROCEDIMIENTO DE PREPARACION, Y LAS COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN | |
| TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
| JO3196B1 (ar) | عملية تحضير ملح ل – ارجينين البيريندوبريل | |
| BR112013030973A8 (pt) | processo para a preparação de amidas de prostaglandina | |
| CR20140325A (es) | Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2- | |
| CL2015001289A1 (es) | Nuevos derivados de 1,4-ditiina sustituida y su uso como fungicidas | |
| EA201600394A1 (ru) | Трициклические соединения пиперидина | |
| EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
| BR112016008704A8 (pt) | derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos | |
| CR20140130A (es) | 2-(croman-6-iloxi)-tiazoles sustituidos y su uso como productos farmacéuticos | |
| CY1117315T1 (el) | Νεα μεθοδος συνθεσης του 3-(2-βρωμο-4,5-διμεθοξυφαινυλ)προπανονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ | |
| AR094866A1 (es) | Formas cristalinas de un inhibidor de la prolil hidroxilasa | |
| GB2527958A (en) | Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |